Skip to content

Study on Influencing Factors and Intervention Program Development for Interoception of Lung Cancer Chemotherapy Patients

Study on Influencing Factors and Intervention Program Development for Interoception of Lung Cancer Chemotherapy Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124749
Enrollment
Unknown
Registered
2026-05-17
Start date
2026-05-19
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Intervention group:Interoceptive intervention: Based on routine care, an interoceptive intervention grounded in the self-regulation knowledge model was implemented, including body sensation awareness
Control group:Participants in the control group will receive routine care and standard health education without additional psychological or behavioral interve

Sponsors

Jiangnan University Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years; 2. Clinically and pathologically diagnosed with primary lung cancer; 3. Have received at least one cycle of chemotherapy; 4. Expected survival time of 3 months or longer; 5. Voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Severe cognitive impairment or inability to independently understand and complete research; 2. Combined with severe organic lesions affecting the heart, liver, kidney function, and other diseases; 3. Patients who are currently undergoing or have recently undergone psychotherapy; 4. Patients with critical illness or severe sensory impairment.

Design outcomes

Primary

MeasureTime frame
interoception;

Secondary

MeasureTime frame
Symptom burden;Anxiety and Depression;level of disease perception;Coping method;Perceived social support;

Countries

China

Contacts

Public ContactTeng Liping

Jiangnan University Affiliated Hospital

2731361982@qq.com+86 173 5520 8709

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 22, 2026